Pro Data Export
Synta Pharmaceuticals Key Statistics
Current Valuation
Dividends and Shares
| Shares Outstanding | 69.13M |
| Dividend | |
| Dividend Yield | 0.00% |
| Cash Div. Payout Ratio TTM Pro | Go Pro |
| Payout Ratio TTM Pro | Go Pro |
| Latest Dividend Date | |
| Latest Ex-Dividend Date | |
| Last Split Factor | |
| Last Split Date |
Profitability
| Gross Profit Margin Quarterly | |
| Profit Margin Quarterly | |
| EBITDA Margin TTM Pro | Go Pro |
| Operating Margin TTM Pro | Go Pro |
Management Effectiveness
Liquidity and Solvency
| Altman Z-Score Pro | Go Pro |
| Current Ratio | 5.551 |
| Debt to Equity Ratio | 0.4174 |
| Free Cash Flow | -22.49M |
| KZ Index Pro | Go Pro |
| Tangible Common Equity Ratio Pro | Go Pro |
| Times Interest Earned TTM Pro | Go Pro |
Stock Price Performance
| Beta Pro | Go Pro |
| 1 Month Stock Returns | -24.17% |
| Year to Date Stock Returns | -16.85% |
| 1 Year Stock Returns | 87.50% |
| 3 Year Stock Returns | 126.6% |
| 52 Week High | 11.88 |
| 52 Week Low | 3.71 |
Income Statement
Cash Flow Statement
| Cash from Financing TTM | 94.74M |
| Cash from Investing TTM | -33.24M |
| Cash from Operations TTM | -61.10M |
| Capital Expenditures Quarterly Pro | Go Pro |
Balance Sheet
| Cash and ST Investments | 90.39M |
| Long Term Debt | 23.63M |
| Total Assets | 93.70M |
| Liabilities | 37.10M |
| Shareholders Equity | 56.60M |
| Book Value | 56.60M |
| Book Value Per Share | 0.8188 |
| Tangible Book Value Pro | Go Pro |
| Tangible Book Value Per Share Pro | Go Pro |
Earnings Quality
| Accruals Pro | Go Pro |
| Beneish M-Score Pro | Go Pro |
SNTA News
Synta Pharma (SNTA) Sell-Off Related to R&D Pres. Resignation, Could Be Buying Opp
Street Insider May 7
Street Insider May 7
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| SNTA | 7.50 | +0.01 | +0.13% | 518.50M |
New watchlist
